Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 (Registration No. 333-_________) of Bone Biologics Corporation (“the Company”) of our report dated March 15, 2022, relating to the financial statements of Bone Biologics Corporation as of December 31, 2021 and 2020, and for the years then ended (which report includes an explanatory paragraph relating to substantial doubt about the Company’s ability to continue as a going concern), which appear in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on March 15, 2022. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
Weinberg & Company, P.A.
Los Angeles, California
June 28, 2022